In animal models, BPC-157 improved healing in tendons and ligaments, including enhanced MCL repair and accelerated Achilles tendon recovery (Cerovecki et al., J Orthop Res, 2010)
Regulatory Status BPC-157 is not approved by Health Canada for human use
The opposite problem occurs with concentrated compounds like GHK-Cu at 50 mg
[PMID: 31101394] PubMed record related to this compound for laboratory literature review
Andrew Huberman, a neuroscience professor at Stanford, has stated publicly that "BPC-157 is one of the more interesting peptides because of the gastric juice origin and the acid stability, but the lack of human trials is a real limitation that people tend to overlook." This sentiment reflects the tension between preclinical promise and clinical evidence gaps
Your next phase may include an adjusted schedule and integration into your broader care program based on your goals and progress